Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8IQ4

Cryo-EM structure of Carboprost-bound prostaglandin-F2-alpha receptor-miniGq-Nb35 complex

Summary for 8IQ4
Entry DOI10.2210/pdb8iq4/pdb
EMDB information35657
DescriptorProstaglandin F2-alpha receptor, Guanine nucleotide-binding protein G(s) subunit alpha isoforms short, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, ... (6 entities in total)
Functional Keywordsgpcr, complex, prostaglandin receptor, agonist, membrane protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains5
Total formula weight133412.35
Authors
Lv, X.,Gao, K.,Nie, J.,Zhang, X.,Zhang, S.,Ren, Y.,Li, Q.,Huang, J.,Liu, L.,Zhang, X.,Sun, X.,Zhang, W.,Liu, X. (deposition date: 2023-03-15, release date: 2024-01-31, Last modification date: 2024-10-16)
Primary citationLv, X.,Gao, K.,Nie, J.,Zhang, X.,Zhang, S.,Ren, Y.,Sun, X.,Li, Q.,Huang, J.,Liu, L.,Zhang, X.,Zhang, W.,Liu, X.
Structures of human prostaglandin F 2 alpha receptor reveal the mechanism of ligand and G protein selectivity.
Nat Commun, 14:8136-8136, 2023
Cited by
PubMed Abstract: Prostaglandins and their receptors regulate various physiological processes. Carboprost, an analog of prostaglandin F and an agonist for the prostaglandin F2-alpha receptor (FP receptor), is clinically used to treat postpartum hemorrhage (PPH). However, off-target activation of closely related receptors such as the prostaglandin E receptor subtype EP3 (EP3 receptor) by carboprost results in side effects and limits the clinical application. Meanwhile, the FP receptor selective agonist latanoprost is not suitable to treat PPH due to its poor solubility and fast clearance. Here, we present two cryo-EM structures of the FP receptor bound to carboprost and latanoprost-FA (the free acid form of latanoprost) at 2.7 Å and 3.2 Å resolution, respectively. The structures reveal the molecular mechanism of FP receptor selectivity for both endogenous prostaglandins and clinical drugs, as well as the molecular mechanism of G protein coupling preference by the prostaglandin receptors. The structural information may guide the development of better prostaglandin drugs.
PubMed: 38065938
DOI: 10.1038/s41467-023-43922-8
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.7 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon